MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ

Real-time Quotes | Nasdaq Last Sale

78.53
-0.37
-0.47%
After Hours: 79.25 +0.72 +0.92% 16:37 05/17 EDT
OPEN
78.34
PREV CLOSE
78.90
HIGH
79.70
LOW
77.50
VOLUME
633.31K
TURNOVER
--
52 WEEK HIGH
123.74
52 WEEK LOW
75.26
MARKET CAP
4.92B
P/E (TTM)
-191.9110
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now
Zacks.com · 11h ago
Research Alert: CFRA Adds Tandem Diabetes Care To Small/mid-cap Growth Model Portfolio
MT Newswires · 11h ago
Formula Growth Ltd Buys Simon Property Group Inc, Micron Technology Inc, Dillard's Inc, Sells ...
GuruFocus News · 21h ago
Rtw Investments, Llc Buys S&P 500 ETF TRUST ETF, Quidel Corp, Tarsus Pharmaceuticals Inc, ...
GuruFocus News · 1d ago
Tandem (TNDM) Global Growth Strong, Costs Continue to Rise
Tandem Diabetes (TNDM) is witnessing high international demand for the t:slim X2 pump.
Zacks · 4d ago
Andar Capital Management HK Ltd Buys Teradata Corp, Twilio Inc, Elastic NV, Sells Nuance ...
GuruFocus News · 4d ago
Tandem Diabetes (TNDM) Q1 Net Loss Narrows, Guidance Up
Zacks · 05/06 13:57
--SVB Leerink Adjusts Price Target on Tandem Diabetes Care to $102 From $95, Maintains Market Perform Rating
MT Newswires · 05/06 12:25
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TNDM. Analyze the recent business situations of Tandem Diabetes through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TNDM stock price target is 127.40 with a high estimate of 150.00 and a low estimate of 99.00.
EPS
Institutional Holdings
Institutions: 418
Institutional Holdings: 68.13M
% Owned: 108.77%
Shares Outstanding: 62.64M
TypeInstitutionsShares
Increased
79
3.54M
New
32
2.02M
Decreased
70
1.89M
Sold Out
45
1.49M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.54%
Healthcare Equipment & Supplies
-0.70%
Key Executives
Chairman/Executive Director
Kim Blickenstaff
President/Chief Executive Officer/Director
John Sheridan
Chief Financial Officer/Executive Vice President/Treasurer
Leigh Vosseller
Executive Vice President/Chief Administrative Officer
Susan Morrison
Executive Vice President/Chief Compliance Officer/Secretary
David Berger
Executive Vice President
Elizabeth Gasser
Executive Vice President
Brian Hansen
Vice President
Jordan Pinsker
Lead Director/Independent Director
Dick Allen
Independent Director
Peyton Howell
Independent Director
Kathleen McGroddy-Goetz
Independent Director
Rebecca Robertson
Independent Director
Douglas Roeder
Independent Director
Rajwant Sodhi
Independent Director
Christopher Twomey
No Data
About TNDM
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. The Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.

Webull offers kinds of Tandem Diabetes Care Inc stock information, including NASDAQ:TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.